SBRA earnings

Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the first quarter of 2026. FIRST QUARTER 2026 RESULTS AND RECENT EVENTS Results per diluted common share for the first quarter of 2026 were as follows: Net Income: $0.16 FFO: $0.37 Normalized FFO: $0.38 AFFO: $0.39 Normalized AFFO: $0.39 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.46x Senior Housing - Leased: 1.58x Behavioral Health, Specialty Hospitals and Other: 4.00x On a year-over-year basis, same property managed senior housing Cash NOI increased 14.4% for the first quarter of 2026. In the first quarter

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2026 first quarter earnings release on April 29, 2026, after the close of trading. A conference call with a simultaneous webcast to discuss the 2026 first quarter results will be held on Thursday, April 30th at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/961345479. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland corp

Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the fourth quarter of 2025. FOURTH QUARTER 2025 RESULTS AND RECENT EVENTS Results per diluted common share for the fourth quarter of 2025 were as follows: Net Income: $0.11 FFO: $0.36 Normalized FFO: $0.36 AFFO: $0.37 Normalized AFFO: $0.38 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.38x Senior Housing - Leased: 1.52x Behavioral Health, Specialty Hospitals and Other: 3.99x On a year-over-year basis, same property managed senior housing Cash NOI increased 12.6% for the fourth quarter of 2025, while the 2025 quarte

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2025 fourth quarter earnings release on February 12, 2026, after the close of trading. A conference call with a simultaneous webcast to discuss the 2025 fourth quarter results will be held on Friday, February 13 at 11:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/141249230. A digital replay of the call will be available on our website at www.sabrahealth.com. Also, on February 2, 2026, Sabra's board of directors d

Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the third quarter of 2025. THIRD QUARTER 2025 RESULTS AND RECENT EVENTS Results per diluted common share for the third quarter of 2025 were as follows: Net Income: $0.09 FFO: $0.33 Normalized FFO: $0.36 AFFO: $0.37 Normalized AFFO: $0.38 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.35x Senior Housing - Leased: 1.52x Behavioral Health, Specialty Hospitals and Other: 3.90x Same store managed senior housing Cash NOI increased 13.3% on a year-over-year basis. Excluding the 16 properties formerly operated by Holiday that remain in

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2025 third quarter earnings release on November 5, 2025, after the close of trading. A conference call with a simultaneous webcast to discuss the 2025 third quarter results will be held on Thursday, November 6th at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/285294519. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland

Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the second quarter of 2025. SECOND QUARTER 2025 RESULTS AND RECENT EVENTS Results per diluted common share for the second quarter of 2025 were as follows: Net Income: $0.27 FFO: $0.44 Normalized FFO: $0.37 AFFO: $0.37 Normalized AFFO: $0.38 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.27x Senior Housing - Leased: 1.49x Behavioral Health, Specialty Hospitals and Other: 3.87x Same store managed senior housing Cash NOI increased 17.1% on a year-over-year basis. In the second quarter of 2025, Sabra acquired a mana

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2025 second quarter earnings release on August 4, 2025, after the close of trading. A conference call with a simultaneous webcast to discuss the 2025 second quarter results will be held on Tuesday, August 5th at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/198851401. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland cor

Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the first quarter of 2025. FIRST QUARTER 2025 RESULTS AND RECENT EVENTS Results per diluted common share for the first quarter of 2025 were as follows: Net Income: $0.17 FFO: $0.36 Normalized FFO: $0.35 AFFO: $0.37 Normalized AFFO: $0.37 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.19x Senior Housing - Leased: 1.41x Behavioral Health, Specialty Hospitals and Other: 3.77x Same store managed senior housing Cash NOI increased 16.9% on a year-over-year basis. During the first quarter of 2025, Sabra exercised its option to ac

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2025 first quarter earnings release on May 5, 2025, after the close of trading. A conference call with a simultaneous webcast to discuss the 2025 first quarter results will be held on Tuesday, May 6th at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/667976677. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland corporation, op

Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the fourth quarter of 2024. FOURTH QUARTER 2024 RESULTS AND RECENT EVENTS Results per diluted common share for the fourth quarter of 2024 were as follows: Net Income: $0.19 FFO: $0.36 Normalized FFO: $0.35 AFFO: $0.36 Normalized AFFO: $0.36 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.09x Senior Housing - Leased: 1.36x Behavioral Health, Specialty Hospitals and Other: 3.66x Same store managed senior housing Cash NOI increased 17.9% on a year-over-year basis. As previously announced, in the fourth quarter of 2024, Sabra cl

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2024 fourth quarter earnings release on February 19, 2025, after the close of trading. A conference call with a simultaneous webcast to discuss the 2024 fourth quarter results will be held on Thursday, February 20 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/595686468. A digital replay of the call will be available on our website at www.sabrahealth.com. Also, on February 3, 2025, Sabra's board of directors

Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the third quarter of 2024. THIRD QUARTER 2024 RESULTS AND RECENT EVENTS Results per diluted common share for the third quarter of 2024 were as follows: Net Income: $0.13 FFO: $0.34 Normalized FFO: $0.35 AFFO: $0.36 Normalized AFFO: $0.37 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 1.94x Senior Housing - Leased: 1.37x Behavioral Health, Specialty Hospitals and Other: 3.68x Same store managed senior housing Cash NOI increased 17.8% on a year-over-year basis. As previously announced, in the third quarter of 2024, Sabra close

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2024 third quarter earnings release on October 31, 2024, after the close of trading. A conference call with a simultaneous webcast to discuss the 2024 third quarter results will be held on Friday, November 1 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/444925126. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland corporat

Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the second quarter of 2024. SECOND QUARTER 2024 RESULTS AND RECENT EVENTS Results per diluted common share for the second quarter of 2024 were as follows: Net Income: $0.10 FFO: $0.35 Normalized FFO: $0.35 AFFO: $0.36 Normalized AFFO: $0.36 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 1.85x Senior Housing - Leased: 1.35x Behavioral Health, Specialty Hospitals and Other: 3.69x Same store managed senior housing Cash NOI increased 17.7% on a year-over-year basis. Investment activity through June 30, 2024 amounts

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2024 second quarter earnings release on August 7, 2024, after the close of trading. A conference call with a simultaneous webcast to discuss the 2024 second quarter results will be held on Thursday, August 8 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/150203568. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland corp

Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the first quarter of 2024. FIRST QUARTER 2024 RESULTS AND RECENT EVENTS Results per diluted common share for the first quarter of 2024 were as follows: Net Income: $0.11 FFO: $0.32 Normalized FFO: $0.34 AFFO: $0.35 Normalized AFFO: $0.35 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 1.79x (1.79x excluding Provider Relief Funds) Senior Housing - Leased: 1.33x Behavioral Health, Specialty Hospitals and Other: 3.77x On May 8, 2024, Sabra's Board of Directors declared a quarterly cash dividend of $0.30 per share of commo

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2024 first quarter earnings release on May 8, 2024, after the close of trading. A conference call with a simultaneous webcast to discuss the 2024 first quarter results will be held on Thursday, May 9 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/588244325. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland corporation,

Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the fourth quarter of 2023. FOURTH QUARTER 2023 RESULTS AND RECENT EVENTS Results per diluted common share for the fourth quarter of 2023 were as follows: Net Income: $0.07 FFO: $0.30 Normalized FFO: $0.32 AFFO: $0.32 Normalized AFFO: $0.33 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 1.78x (1.72x excluding Provider Relief Funds) Senior Housing - Leased: 1.28x Behavioral Health: 1.85x Specialty Hospitals & Other: 7.00x During the fourth quarter of 2023, Sabra expanded its relationship with Ignite Medical Resorts

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2023 fourth quarter earnings release on February 27, 2024, after the close of trading. A conference call with a simultaneous webcast to discuss the 2023 fourth quarter results will be held on Wednesday, February 28 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-596-4144. For participants outside the U.S., the dial-in number is 646-968-2525. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/290282806. A digital replay of the call will be available on our website at www.sabrahealth.com. Also, on February 1, 2024, Sabra's board of director

Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the third quarter of 2023. THIRD QUARTER 2023 RESULTS AND RECENT EVENTS Results per diluted common share for the third quarter of 2023 were as follows: Net Loss: $(0.07) FFO: $0.33 Normalized FFO: $0.33 AFFO: $0.35 Normalized AFFO: $0.34 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 1.68x (1.61x excluding Provider Relief Funds) Senior Housing - Leased: 1.17x Behavioral Health: 1.92x Specialty Hospitals & Other: 6.72x During the third quarter of 2023, Sabra generated $80 million of gross proceeds from the dispositi

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2023 third quarter earnings release on November 6, 2023, after the close of trading. A conference call with a simultaneous webcast to discuss the 2023 third quarter results will be held on Tuesday, November 7 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/646608122. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland cor

Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the second quarter of 2023. SECOND QUARTER 2023 RESULTS AND RECENT EVENTS Results per diluted common share for the second quarter of 2023 were as follows: Net Income: $0.09 FFO: $0.32 Normalized FFO: $0.33 AFFO: $0.33 Normalized AFFO: $0.34 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 1.65x (1.57x excluding Provider Relief Funds) Senior Housing - Leased: 1.15x Behavioral Health: 1.87x Specialty Hospitals & Other: 6.68x During the second quarter of 2023, Sabra generated $18 million of gross proceeds from the dispo

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2023 second quarter earnings release on August 7, 2023, after the close of trading. A conference call with a simultaneous webcast to discuss the 2023 second quarter results will be held on Tuesday, August 8 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/659208545. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland corpo

Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the first quarter of 2023. FIRST QUARTER 2023 RESULTS AND RECENT EVENTS Results per diluted common share for the first quarter of 2023 were as follows: Net Loss: $(0.04) FFO: $0.32 Normalized FFO: $0.33 AFFO: $0.33 Normalized AFFO: $0.34 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 1.63x 1.55x (excluding Provider Relief Funds "PRF") - up from 1.48x in the prior quarter Senior Housing - Leased: 1.14x Behavioral Health: 1.71x Specialty Hospitals & Other: 6.40x During the first quarter of 2023, we closed on the

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2023 first quarter earnings release on May 3, 2023, after the close of trading. A conference call with a simultaneous webcast to discuss the 2023 first quarter results will be held on Thursday, May 4 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/528327157. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland corporation,

Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the fourth quarter of 2022. FOURTH QUARTER 2022 RESULTS AND RECENT EVENTS Results per diluted common share for the fourth quarter of 2022 were as follows: Net Loss: $(0.37) FFO: $0.25 Normalized FFO: $0.37 AFFO: $0.34 Normalized AFFO: $0.37 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 1.77x (pro forma for North American transition, Avamere lease amendment) 1.54x (pro forma for North American transition, Avamere lease amendment, and excluding Provider Relief Funds) Senior Housing - Leased: 1.19x Behavioral Health: 1.71x Spec

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2022 fourth quarter earnings release on February 21, 2023, after the close of trading. A conference call with a simultaneous webcast to discuss the 2022 fourth quarter results will be held on Wednesday, February 22 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/407563855. A digital replay of the call will be available on our website at www.sabrahealth.com. Also, on February 1, 2023, Sabra's board of directors d

Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the third quarter of 2022. In addition, the Company provided a business update. THIRD QUARTER 2022 RESULTS AND RECENT EVENTS Results per diluted common share for the third quarter of 2022 were as follows: Net Loss: $(0.22) FFO: $0.28 Normalized FFO: $0.36 AFFO: $0.34 Normalized AFFO: $0.35 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 1.83x (pro forma for North American transition, Avamere lease amendment) 1.60x (pro forma for North American transition, Avamere lease amendment, and excluding Provider Relief Funds) Senior Housing

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2022 third quarter earnings release on November 7, 2022 after the close of trading. A conference call with a simultaneous webcast to discuss the 2022 third quarter results will be held on Tuesday, November 8 at 10:00 a.m. Pacific Time. The webcast URL is https://edge.media-server.com/mmc/p/eyzpt5x9. To participate via telephone, please register in advance at https://register.vevent.com/register/BId527bdd7b5cd4bd685268d3255d6aed6 to receive a unique PIN needed to access the call. The dial-in number is (844) 543-0451. A digital replay of the call will be available on our website at www.sabrahealth.com. About S

Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the second quarter of 2022. In addition, the Company provided a business update. SECOND QUARTER 2022 RESULTS AND RECENT EVENTS Results per diluted common share for the second quarter of 2022 were as follows: Net Income: $0.07 FFO: $0.36 Normalized FFO: $0.39 AFFO: $0.36 Normalized AFFO: $0.38 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 1.88x (pro forma for Avamere lease amendment), and 1.66x (pro forma for Avamere lease amendment and excluding Provider Relief Funds) Senior Housing - Leased: 1.09x Behavioral Health: 1.83x Special

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2022 second quarter earnings release on August 3, 2022 after the close of trading. A conference call with a simultaneous webcast to discuss the 2022 second quarter results will be held on Thursday, August 4 at 10:00 a.m. Pacific Time. The webcast URL is https://edge.media-server.com/mmc/p/8y4hfs37. To participate via telephone, please register in advance at https://register.vevent.com/register/BIc05c360c08b0486980f4d682637b42b2 to receive a unique PIN needed to access the call. The dial-in number is (844) 543-0451. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sa

Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the first quarter of 2022. In addition, the Company provided a business update. FIRST QUARTER 2022 RESULTS AND RECENT EVENTS Results per diluted common share for the first quarter of 2022 were as follows: Net Income: $0.18 FFO: $0.39 Normalized FFO: $0.38 AFFO: $0.39 Normalized AFFO: $0.38 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 1.87x (pro forma for Avamere lease amendment) Senior Housing - Leased: 1.02x Behavioral Health: 1.98x Specialty Hospitals & Other: 7.52x We have collected 99.5% of our forecasted rents from the

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2022 first quarter earnings release on May 4, 2022 after the close of trading. A conference call with a simultaneous webcast to discuss the 2022 first quarter results will be held on Thursday, May 5 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 844-862-3710. For participants outside the U.S., the dial-in number is 612-979-9902. The conference ID number is 2691005. The webcast URL is https://edge.media-server.com/mmc/p/2yhgcmqz. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland corporation, ope

Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the fourth quarter of 2021. In addition, the Company provided a business update. FOURTH QUARTER 2021 RESULTS AND RECENT EVENTS Results per diluted common share for the fourth quarter of 2021 were as follows: Net Loss: $(0.11) FFO: $0.11 Normalized FFO: $0.39 AFFO: $0.20 Normalized AFFO: $0.37 Included in net loss and FFO is the acceleration of amortization of the remaining $18.6 million ($0.08 per diluted common share) above-market lease intangible related to our lease with the Avamere Family of Companies ("Avamere"). This acceleration of amortization come

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2021 fourth quarter earnings release on February 22, 2022 before the market opens. A conference call with a simultaneous webcast to discuss the 2021 fourth quarter results will be held on the same day at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 844-862-3710. For participants outside the U.S., the dial-in number is 612-979-9902. The conference ID number is 3672788. The webcast URL is https://edge.media-server.com/mmc/p/r5to66um. A digital replay of the call will be available on our website at www.sabrahealth.com. Also, on February 1, 2022, Sabra's board of directors declared a qua

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2021 third quarter earnings release on November 3, 2021. A conference call with a simultaneous webcast to discuss the 2021 third quarter results will be held on Thursday, November 4 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 844-862-3710. For participants outside the U.S., the dial-in number is 612-979-9902. The conference ID number is 2558322. The webcast URL is https://edge.media-server.com/mmc/p/xt9n4b8b. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland corporation, operates as a self-a

Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced results of operations for the second quarter of 2021. In addition, the Company announced its intention to exit from the Enlivant Joint Venture, provided a business update and provided guidance for the full year 2021. SECOND QUARTER 2021 RESULTS AND RECENT EVENTS Following are the highlights of our results for the second quarter of 2021 and recent events: For the second quarter of 2021, net loss, FFO, Normalized FFO, AFFO and Normalized AFFO per diluted common share were $(0.61), $0.39, $0.41, $0.39 and $0.40, respectively. Included in the net loss per diluted common share is a $(0.76) impairment

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2021 second quarter earnings release on August 4, 2021. A conference call with a simultaneous webcast to discuss the 2021 second quarter results will be held on Thursday, August 5 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 844-862-3710. For participants outside the U.S., the dial-in number is 612-979-9902. The conference ID number is 8140736. The webcast URL is https://edge.media-server.com/mmc/p/yh6f347a. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland corporation, operates as a self-adm